Case 22: Alpelisib-Induced Hyperglycemia: A Case Series

Abstract

Case 1, a 62-year-old female with recurrent invasive ductal carcinoma metastatic to lung and bone, was referred to Endocrinology for management of hyperglycemia. Case 2, a 47-year-old female with history of major depressive disorder, generalized anxiety disorder, and recurrent metastatic breast cancer, was referred to Endocrinology for management of alpelisib-induced diabetes. Case 3, a 59-year-old female with metastatic invasive ductal carcinoma, gastroesophageal reflux disease, and chronic low back pain, was diagnosed with alpelisib-induced diabetes.